anonymous
Guest
anonymous
Guest
Just heard about Joe!
Can not believe after 20yrs JB leaves I&I.
He was one of orginal 8 Xeljanz DMs & even Director of Operations for Xeljanz/I&I.
Word is he is going to be a Director w Gilead Biotech's new Immunology Division with a strong revolutionary genetic therapy pipeline in Immunology from recent Galapagos purchase.
Launching the division w clean JAK for bridge into the genetic therapy field of Immunology.
Must have been a hell of a Windfall Package to leave 20 yrs of Pfizer on the table.
Good for him & his family as he was one of the few good ones left.
Can not believe after 20yrs JB leaves I&I.
He was one of orginal 8 Xeljanz DMs & even Director of Operations for Xeljanz/I&I.
Word is he is going to be a Director w Gilead Biotech's new Immunology Division with a strong revolutionary genetic therapy pipeline in Immunology from recent Galapagos purchase.
Launching the division w clean JAK for bridge into the genetic therapy field of Immunology.
Must have been a hell of a Windfall Package to leave 20 yrs of Pfizer on the table.
Good for him & his family as he was one of the few good ones left.